Funds holding Guangdong Hybribio Biotech Co Ltd
ISIN CNE100002N51 · China · LEI 655600IZO2GZ4A2SFO89
- Fund holders
- 2
- Of which ETFs
- 1 1 other fund
- Value held
- 131.5K $
2 tracked funds declare this company. So these figures do not say who owns it.
| Fund | Shares | Value | Weight in fund | |
|---|---|---|---|---|
| VANGUARD EMERGING MARKETS STOCK INDEX FUND VANGUARD INTERNATIONAL EQUITY INDEX FUNDS | 147,820 | 121.7K $ | 0.00 % | as of Jul 31, 2026 ↗ |
| Dimensional Emerging Markets Value ETF Dimensional ETF Trust | 12,000 | 9.9K $ | 0.00 % | as of Jul 31, 2026 ↗ |
The funds most exposed to it
The weight is the share of a fund's net assets. The holders table ranks funds by number of shares. This one ranks them by the weight of the company in each fund.
| Fund | Weight in fund | |
|---|---|---|
| Dimensional Emerging Markets Value ETF Dimensional ETF Trust | 0.00 % | as of Jul 31, 2026 ↗ |
| VANGUARD EMERGING MARKETS STOCK INDEX FUND VANGUARD INTERNATIONAL EQUITY INDEX FUNDS | 0.00 % | as of Jul 31, 2026 ↗ |
Quarter after quarter
Each row is one quarter of SEC filings, newest first. The change compares each quarter with the one before.
| Quarter | Holders | Change | Shares | Change |
|---|---|---|---|---|
| 2026Q3 | 2 | 0 | 159,820 | 0.0 % |
| 2026Q2 | 2 | 0 | 159,820 | -76.4 % |
| 2026Q1 | 2 | 0 | 676,420 | 0.0 % |
| 2025Q4 | 2 | 0 | 676,420 | 0.0 % |
| 2025Q3 | 2 | -1 | 676,420 | -0.1 % |
| 2025Q2 | 3 | -3 | 676,770 | -8.0 % |
| 2025Q1 | 6 | -8 | 735,433 | -67.9 % |
| 2024Q4 | 14 | 0 | 2,288,439 | -0.6 % |
| 2024Q3 | 14 | -4 | 2,301,714 | -4.4 % |
| 2024Q2 | 18 | +3 | 2,407,764 | +165.7 % |
| 2024Q1 | 15 | -4 | 906,200 | -64.8 % |
| 2023Q4 | 19 | 2,574,542 |
Cite this page
Titelia. "Funds holding Guangdong Hybribio Biotech Co Ltd". https://titelia.com/en/stocks/guangdong-hybribio-biotech-co-ltd-CNE100002N51